Dr. Reddy launches Sildenafil tablets

India Infoline News Service | Mumbai |

The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.

Dr. Reddy's Laboratories announced today that it has launched Sildenafil Tablets (20 mg), a bioequivalent generic version of REVATIO® (Sildenafil) Tablets in the US market on November16, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Sildenafil Tablets.


The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.


Dr. Reddy's Sildenafil Tablets in 20 mg are available in 90 count bottle sizes.

BSE 2,466.15 [54.40] ([2.16]%)
NSE 2,463.75 [53.05] ([2.11]%)

***Note: This is a NSE Chart

 

Advertisements

  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.
welcome to iifl